Cargando…

Muscle wasting as an independent predictor of survival in patients with chronic heart failure

BACKGROUND: Skeletal muscle wasting is an extremely common feature in patients with heart failure, affecting approximately 20% of ambulatory patients with even higher values during acute decompensation. Its occurrence is associated with reduced exercise capacity, muscle strength, and quality of life...

Descripción completa

Detalles Bibliográficos
Autores principales:	von Haehling, Stephan, Garfias Macedo, Tania, Valentova, Miroslava, Anker, Markus S., Ebner, Nicole, Bekfani, Tarek, Haarmann, Helge, Schefold, Joerg C., Lainscak, Mitja, Cleland, John G. F., Doehner, Wolfram, Hasenfuss, Gerd, Anker, Stefan D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7567155/ https://www.ncbi.nlm.nih.gov/pubmed/32767518 http://dx.doi.org/10.1002/jcsm.12603

Ejemplares similares

Anorexia, functional capacity, and clinical outcome in patients with chronic heart failure: results from the Studies Investigating Co‐morbidities Aggravating Heart Failure (SICA‐HF)
por: Saitoh, Masakazu, et al.
Publicado: (2017)

The obesity paradox in chronic disease: facts and numbers
por: Lainscak, Mitja, et al.
Publicado: (2012)

Heart failure and sleep‐disordered breathing: susceptibility to reduced muscle strength and preclinical congestion (SICA‐HF cohort)
por: Bekfani, Tarek, et al.
Publicado: (2020)

Evaluation of C‐terminal Agrin Fragment as a marker of muscle wasting in patients after acute stroke during early rehabilitation
por: Scherbakov, Nadja, et al.
Publicado: (2015)

Body weight changes and incidence of cachexia after stroke
por: Scherbakov, Nadja, et al.
Publicado: (2019)

Single baseline serum creatinine measurements predict mortality in critically ill patients hospitalized for acute heart failure
por: Schefold, Joerg C., et al.
Publicado: (2015)

Highlights from the 7th Cachexia Conference: muscle wasting pathophysiological detection and novel treatment strategies
por: Ebner, Nicole, et al.
Publicado: (2014)

Growth hormone, insulin-like growth factor 1, and insulin signaling—a pharmacological target in body wasting and cachexia
por: Trobec, Katja, et al.
Publicado: (2011)

Non-invasive assessment of cardiac hemodynamics in patients with advanced cancer and with chronic heart failure: a pilot feasibility study
por: von Haehling, Stephan, et al.
Publicado: (2013)

Cardiac cachexia: hic et nunc
por: Loncar, Goran, et al.
Publicado: (2016)

Body mass index and prognosis in patients hospitalized with acute exacerbation of chronic obstructive pulmonary disease
por: Lainscak, Mitja, et al.
Publicado: (2011)

Iron Deficiency and Reduced Muscle Strength in Patients with Acute and Chronic Ischemic Stroke
por: Scherbakov, Nadja, et al.
Publicado: (2022)

Sleep‐Disordered Breathing in Acute Ischemic Stroke: A Mechanistic Link to Peripheral Endothelial Dysfunction
por: Scherbakov, Nadja, et al.
Publicado: (2017)

Recent developments in the treatment of cachexia: highlights from the 6th Cachexia Conference
por: Ebner, Nicole, et al.
Publicado: (2012)

Erratum to: Recent developments in the treatment of cachexia: highlights from the 6th Cachexia Conference
por: Ebner, N., et al.
Publicado: (2012)

Magnetic resonance imaging of organ iron before and after correction of iron deficiency in patients with heart failure
por: Gertler, Christoph, et al.
Publicado: (2023)

Recent developments in the field of cachexia, sarcopenia, and muscle wasting: highlights from the 11th Cachexia Conference
por: Ebner, Nicole, et al.
Publicado: (2019)

Recent developments in the field of cachexia, sarcopenia, and muscle wasting: highlights from the 12th Cachexia Conference
por: Ebner, Nicole, et al.
Publicado: (2020)

Early rehabilitation after stroke: relationship between the heart rate variability and functional outcome
por: Scherbakov, Nadja, et al.
Publicado: (2020)

MT‐102 prevents tissue wasting and improves survival in a rat model of severe cancer cachexia
por: Pötsch, Mareike S., et al.
Publicado: (2020)

Predictors of lower exercise capacity in patients with cancer
por: Evertz, Ruben, et al.
Publicado: (2023)

Heart failure, chronic obstructive pulmonary disease, and asthma: numbers, facts, and challenges
por: Lainscak, Mitja, et al.
Publicado: (2015)

Diabetes mellitus, cachexia and obesity in heart failure: rationale and design of the Studies Investigating Co-morbidities Aggravating Heart Failure (SICA-HF)
por: von Haehling, Stephan, et al.
Publicado: (2010)

Micronutrient Depletion in Heart Failure: Common, Clinically Relevant and Treatable
por: Cvetinovic, Natasa, et al.
Publicado: (2019)

Leukocyte Redistribution: Effects of Beta Blockers in Patients with Chronic Heart Failure
por: von Haehling, Stephan, et al.
Publicado: (2009)

Pharmacokinetics of Drugs in Cachectic Patients: A Systematic Review
por: Trobec, Katja, et al.
Publicado: (2013)

Cachexia as a major public health problem: frequent, costly, and deadly
por: Farkas, Jerneja, et al.
Publicado: (2013)

Cardiovascular and metabolic determinants of quality of life in patients with cancer
por: Evertz, Ruben, et al.
Publicado: (2022)

IGF-1 treatment reduces weight loss and improves outcome in a rat model of cancer cachexia
por: Schmidt, Katja, et al.
Publicado: (2011)

Ursodeoxycholic acid treatment in a rat model of cancer cachexia
por: Tschirner, Anika, et al.
Publicado: (2011)

Cachexia in heart disease: highlights from the ESC 2010
por: Kung, Thomas, et al.
Publicado: (2011)

Time to jump on the bandwagon: the Journal of Cachexia, Sarcopenia and Muscle in 2018
por: von Haehling, Stephan, et al.
Publicado: (2018)

The effects of a high-caloric protein-rich oral nutritional supplement in patients with chronic heart failure and cachexia on quality of life, body composition, and inflammation markers: a randomized, double-blind pilot study
por: Rozentryt, Piotr, et al.
Publicado: (2010)

Efforts begin to sprout: publications in JCSM on cachexia, sarcopenia and muscle wasting receive attention
por: Anker, Stefan D., et al.
Publicado: (2014)

Muscle mass, muscle strength, and functional capacity in patients with heart failure of Chagas disease and other aetiologies
por: da Fonseca, Guilherme Wesley Peixoto, et al.
Publicado: (2020)

Once I get on a puzzle, I can't get off: Cachexia and wasting in 2018
por: von Haehling, Stephan, et al.
Publicado: (2018)

Influence of essential amino acids on muscle mass and muscle strength in patients with cerebral stroke during early rehabilitation: protocol and rationale of a randomized clinical trial (AMINO-Stroke Study)
por: Scherbakov, Nadja, et al.
Publicado: (2016)

Iohexol clearance is superior to creatinine-based renal function estimating equations in detecting short-term renal function decline in chronic heart failure
por: Cvan Trobec, Katja, et al.
Publicado: (2015)

The role of myostatin in muscle wasting: an overview
por: Elkina, Yulia, et al.
Publicado: (2011)

From muscle wasting to sarcopenia and myopenia: update 2012
por: von Haehling, Stephan, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_dqfmloaieg5192r2vqcufp1tll